![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2004, Cold Spring Harbor Laboratory Press The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans Elixir Pharmaceuticals, Cambridge, Massachusetts 02139, USA 1Corresponding author.E-MAIL japfeld/at/elixirpharm.com; FAX (617) 995-7014. Received August 27, 2004; Accepted October 18, 2004. This article has been corrected. See Genes Dev. 2005 January 1; 19(1): 188. This article has been corrected. See Genes Dev. 2005 February 1; 19(3): 411. This article has been cited by other articles in PMC.Abstract Although limiting energy availability extends lifespan in many organisms, it is not understood how lifespan is coupled to energy levels. We find that the AMP:ATP ratio, a measure of energy levels, increases with age in Caenorhabditis elegans and can be used to predict life expectancy. The C. elegans AMP-activated protein kinase α subunit AAK-2 is activated by AMP and functions to extend lifespan. In addition, either an environmental stressor that increases the AMP:ATP ratio or mutations that lower insulin-like signaling extend lifespan in an aak-2-dependent manner. Thus, AAK-2 is a sensor that couples lifespan to information about energy levels and insulin-like signals. Keywords: Aging, C. elegans, AMPK, insulin signaling, FOXO, energy levels Interventions that limit energy availability extend lifespan in an array of organisms (Weindruch and Sohal 1997; Osiewacz 2002; Tissenbaum and Guarente 2002). A common method to limit energy is dietary restriction, which leads to lifespan extension in organisms as diverse as yeasts, nematodes, and rodents (Lakowski and Hekimi 1998; Longo and Finch 2003). However, little is known about how aging is coupled to information about the energy state of the animal. In humans, aging is accompanied by an increase in mitochondrial dysfunction in muscle (Petersen et al. 2003), which is expected to lower cellular energy levels. Similarly, senescent human fibroblasts have a higher AMP:ATP ratio, a sensitive measure of energy levels, than do young fibroblasts (Hardie and Hawley 2001; Wang et al. 2003). We speculated that animals actively sense changes in energy levels and respond by adjusting their lifespan. To investigate this possibility, we studied the role of an AMP-activated protein kinase (AMPK) in the regulation of lifespan in Caenorhabditis elegans. AMPK belongs to a conserved family of eukaryotic protein kinases that function as energy sensors to coordinate the response to conditions that lower energy levels (Hardie and Hawley 2001). For example, when energy availability is limited in rodents, AMPK functions to restore normal energy levels by stimulating glucose uptake in skeletal muscle and glycolysis in the heart and by promoting feeding by regulating a hypothalamic circuit (Marsin et al. 2000; Mu et al. 2001; Andersson et al. 2004; Minokoshi et al. 2004). AMPK is activated by AMP and inhibited by ATP via an allosteric mechanism. Thus, AMPK is a sensor of low energy levels and becomes active when the AMP:ATP ratio is high. AMPK is a heterotrimeric complex that consists of a catalytic α subunit and regulatory β and γ subunits. Here, we report that the C. elegans AMPK α subunit AAK-2 is activated by AMP and functions to extend lifespan. We find that a high-temperature pulse (HTP), an environmental stressor that lowers energy levels, extends lifespan and lowers fertility in an aak-2-dependent manner. Insulin-like signaling regulates lifespan in C. elegans, Drosophila, and rodents (Tissenbaum and Guarente 2002); and we find that aak-2 and daf-16/FOXO function in parallel to mediate the lifespan extension of daf-2/Insulin-like Receptor mutants. Together, our findings indicate that AAK-2 is a sensor that couples lifespan to information about energy levels and insulin-like signals. Results and Discussion To investigate whether changes in energy levels are part of the normal aging process in C. elegans, we first measured the AMP:ATP ratio as a function of age. The AMP:ATP ratio in living animals increases from <0.1 at day 4 of adulthood to 0.8 at day 18, an age near the maximum lifespan of the population (Fig. 1A
Since energy levels decrease with age and predict life expectancy in C. elegans, a mechanism that senses energy levels may function to regulate lifespan. One possible candidate is the AMPK complex (Hardie and Hawley 2001). We identified two AMPKα subunit homologs in C. elegans, AAK-1 and AAK-2, which are 52% and 40% identical to human AMPKα1, respectively, and are also related to the invertebrate SNF1 proteins (Fig. 2A
To determine whether AAK-2 possesses AMPK activity, we asked whether it can phosphorylate a classical AMPK substrate, the SAMS peptide, and whether it is regulated by AMP and phosphorylation (Davies et al. 1989; Stein et al. 2000). An AAK-2-GFP fusion protein immunoprecipitated from C. elegans extracts phosphorylates the SAMS peptide. Moreover, its kinase activity is increased by a factor of three by AMP, with a half-maximal effect at 2.3 μM (Fig. 2D We also studied the role of aak-2 in the context of other conditions that affect lifespan. In many organisms, lifespan can be extended by a sublethal dose of a stressor early in life (hormesis) (Minois 2000). In C. elegans, treatment early in life with a pulse of high temperature, high oxygen pressure, or oxidative stress extends lifespan (Cypser and Johnson 2002). We asked whether environmental stressors influence the AMP:ATP ratio. Exposure of C. elegans to high temperature, starvation, or mitochondrial poisoning causes an increase in the AMP:ATP ratio, which is reversed upon return to normal growth conditions (Fig. 3A
We reasoned that the inability to sense and respond to stress-induced increases in the AMP:ATP ratio may render aak-2 mutants less able to cope with stress. Indeed, aak-2(ok524) mutants are more sensitive than wild-type animals to killing by either high temperature (Fig. 3C We also asked whether aak-2 plays a role in the insulin-like signaling pathway that regulates lifespan (Tissenbaum and Guarente 2002). Reduction-of-function mutations affecting the insulin-like receptor DAF-2 extend lifespan (Kenyon et al. 1993). We measured the lifespans of aak-2(ok524) mutants and daf-2(m577) mutants, as well as daf-2(m577); aak-2(ok524) double mutants. daf-2(m577); aak-2(ok524) double mutants have lifespans that are indistinguishable from those of aak-2(ok524) single mutants (Fig. 4A We also examined the role of aak-2 in the regulation of dauer formation, another process regulated by the insulin-like signaling pathway. At high temperature, juvenile daf-2 mutants enter a state of diapause (called “dauer”) instead of growing into fertile adults (Riddle and Albert 1997). Rather than arresting as dauers, the daf-2; aak-2 double mutants grow into fertile adults at 25°C (Fig. 4B
The FOXO transcription factor DAF-16 is required for the lifespan extension of insulin-like pathway mutants (Kenyon et al. 1993; Tissenbaum and Guarente 2002). If aak-2 extends lifespan solely by activating daf-16 or mediating its activity, then absence of aak-2 activity should not further reduce the lifespans of daf-16(mu86) null mutants (Lin et al. 1997). Instead, daf-16(mu86); aak-2(ok524) double mutants have 15% shorter lifespans than either single mutant (Fig. 4A Recent studies have shown that the LKB1 kinase, a tumor suppressor implicated in a broad range of cellular processes, can activate AMPK by direct phosphorylation (Hawley et al. 2003; Woods et al. 2003; Shaw et al. 2004). The C. elegans homolog of lkb1, par-4, plays a role in the regulation of cell polarity in the early embryo (Watts et al. 2000). We asked whether par-4, like aak-2, also plays a role in the regulation of lifespan and dauer formation. Because par-4 mutants die during early embryogenesis, we used the temperature-sensitive par-4 allele it47 to bypass the embryonic requirement for par-4 activity. We found par-4(it47ts) partially suppresses the lifespan extension and dauer-constitutive phenotypes of daf-2(e1368) mutants (Supplementary Fig. 4). PAR-4 and AAK-2 may function in a common pathway, consistent with PAR-4 activation of AAK-2, since par-4 and aak-2 mutants cause similar post-embryonic phenotypes. Our findings highlight AAK-2 as a key component of a circuit in C. elegans that regulates lifespan in response to environmental stressors and insulin-like signaling (Fig. 4C Materials and methods General methods and strains Wild-type C. elegans was Bristol N2. Unless noted, experiments were performed at 20°C. All experiments involving fem-1(hc17); fer-15(b26) were conducted at 25°C. The following genes and mutations were used: LG I: daf-16(mu86); LG II: fer-15(b26); LG III: daf-2(e1368), daf-2(e1370), daf-2(m577); LG IV: fem-1(hc17), par-4(it47); LG X: aak-2(ok524). Gene identification and sequencing We identified two C. elegans AMPK α subunits (aak-2/T01C8.1 and aak-1/PAR2.3) in WormBase (http://www.wormbase.org, release WS98) by BlastP search with the protein sequences of the human subunits. We confirmed the sequence of aak-2. The ok524 allele of aak-2, generated by the C. elegans Gene Knockout Consortium (http://www.celeganskoconsortium.omrf.org), contains a 409-nucleotide deletion between exon 3 and intron 3, resulting in the insertion of a stop codon. The predicted transcript encodes a protein that truncates after amino acid 164 and, therefore, lacks a complete kinase domain as well as the inhibitory and AMPKβγ-binding domains (Supplementary Fig. 1). Therefore, the ok524 allele is presumed to be a molecular null. Construction of strains Double mutants were constructed by crossing aak-2(ok524) males to the hermaphrodites with the desired second mutation, allowing individual F1 progeny to self-fertilize, then identifying F2 animals with the phenotype corresponding to the second mutation, transferring these animals to individual plates and identifying aak-2(ok524) homozygotes among their progeny by PCR using primers ATGTCGTTGGAAAGATTCGC and CAATGCTGAGGTGACTTCCTCTTCG. The 27°C Daf-c phenotype was used to identify daf-2 mutants. daf-16(mu86) and daf-16(+) were distinguished by PCR (Lin et al. 1997). daf-2(e1368); par-4(it47ts) double mutants were constructed following a similar scheme, starting with par-4(it47ts) heterozygous males. par-4(it47) homozygotes were identified as animals whose progeny were all Emb at 25°C. Transgenic animals Transformation rescue was performed using microinjection of 100 ng/mL PCR-amplified DNA fragments to generate extrachromosomal arrays. The aak-2 genomic fragment, generated using primers TGGGATTCCGTCAAAGAAGGACATG and AACAGAAACAATCACTCGCTGAAGG, contains 3.0 kb and 1.2 kb of DNA upstream and downstream, respectively, of the aak-2 coding sequence. This transgene fully rescues the dauer-defective and lifespan phenotypes of daf-2(e1368); aak-2(ok524) double mutants. The cc::GFP construct (provided by P. Sengupta) expresses GFP in the coelomocytes and was used as a transformation marker. The AAK-2-GFP construct was generated by PCR-fusion of the aak-2 genomic region and a GFP cDNA with an unc-54 3′ UTR from pPD95.77, using primers GAAGAGATGAAAAGAGTGGCGGTATGCC, AGGGTCCTCCTGAAAATGTTCCCGAGCCAGTGTTCCAATCAATGC, GCATTGATTGGAACACTGGCTCGGGAACATTTTCAGGAGGACCCT, and AAGGGCCCGTACGGCCGACTAGTAGG as described (Hobert 2002). daf-2(e1368); aak-2(ok524); fyIs2[AAK-2-GFP 100 ng/mL] was generated by integration of the extrachromosomal array by irradiation with ultraviolet light (254 nm) and out-crossed four times to wild type. fyIs2 fully rescues the Daf-d phenotype of daf-2(e1368); aak-2(ok524) at 25°C. Kinase assays About 10,000 fyIs2 animals were lysed using a 30-sec pulse from a sonicator in 250 μL of IP buffer (50 mM Tris at pH 7.5, 50 mM NaCl, 50 mM NaF, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 5 mM sodium pyrophosphate, 1mM PMSF, 10 mM β glycerophosphate, 1 mM NaVO4, and a protease inhibitor cocktail [Roche]). Approximately 1 mg of protein extract was incubated with rabbit polyclonal anti-GFP antibody ab290 (Abcam) and immunoprecipitated with protein G Sepharose beads (Amersham) in IP buffer. Immune complexes were collected by brief centrifugation and washed extensively in IP Buffer. AMPK activity in the immunoprecipitates was determined by phosphorylation of the SAMS peptide (HMRSAMSGLHLVKRR) as described (Hardie et al. 2000) using [γ-33P] ATP and counted in a MicroBeta TriLux liquid scintillation counter (PerkinElmer). Autoradiography of the kinase reactions resolved by SDS-PAGE confirmed that the SAMS peptide was phosphorylated. When appropriate, immunoprecipitates were dephosphorylated with 0.5 units of recombinant rabbit protein phosphatase-1 (NEB) for 30 min at 30°C and then washed three times in IP buffer before the SAMS assay. Lifespan assays Lifespan assays were performed as described (Apfeld and Kenyon 1999). At the L4 molt, animals were transferred to plates containing 20 μM 5-fluoro-2′-deoxyuridine (FUDR, Sigma), which kills their progeny as embryos. Control experiments indicated that this concentration of FUDR does not significantly affect lifespan. We used the L4 molt as t = 0 for lifespan analysis. Life expectancy at each age was calculated as the remaining mean lifespan of the animals that were alive at that age. Assessment of viability and movement was performed as described (Herndon et al. 2002). We used JMP 5.0 (SAS) software to carry out all statistical analysis and to determine means and percentiles. Nucleotide measurements Perchloric acid extracts were obtained by adapting the method reported by Stocchi et al. (1985) to C. elegans. Between 100 and 400 hand-picked live worms were washed with M9 buffer (22 mM KH2PO4, 34 mM K2HPO4, 86 mM NaCl, 1 mM MgSO4 in H2O) and resuspended in 20 μL of M9 buffer. Forty microliters of ice-cold 8% (v/v) HClO4 was added and immediately followed by three intervals of 30 sec of sonication and 30 sec on ice. The solution was neutralized with 1 N KHCO3 and centrifuged briefly, and the supernatant was passed through a 0.2-μm filter (Nanosep), and subjected to reversed phase chromatography using a Targa C18 250 × 4.6 mm 5-μm column as described (Stocchi et al. 1985). Nucleotides were detected at 260 nm with a Waters 486 tunable detector. Peak areas were measured using Peak Explorer software. Nucleotide identities were confirmed by comigration with known standards. Unless noted, animals were 1-d-old adults. Other assays Dauer assays, high-temperature treatment, measurements of brood size, and behavioral assays were performed as described (Lithgow et al. 1994; Apfeld and Kenyon 1999; Feng et al. 2001). Starvation was performed by transfer to bacteria-free, peptone-free plates. Treatment with 1 mM sodium azide was performed by transfer to plates with the compound. Gut fluorescence was photographed on the focal plane of the lumen with a DM505 filter on a Nikon E800 microscope. Average intensity was determined with Metamorph 6.1r1 software. Acknowledgments We thank Piali Sengupta for providing the cc::GFP construct; Mary Sym, Douglas Crawford, Andrew Dillin, Natasha Libina, and Joy Alcedo for protocols; Jennifer Whangbo, Cynthia Kenyon, Lenny Guarente, and members of the Kenyon Lab and Elixir for helpful discussions and comments on the manuscript; and the Elixir community for support and encouragement. Some of the C. elegans strains used in this work were provided by the Caenorhabditis Genetics Center. Notes Supplemental material is available at http://www.genesdev.org. Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1255404. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
N Engl J Med. 1997 Oct 2; 337(14):986-94.
[N Engl J Med. 1997]Ageing Res Rev. 2002 Jun; 1(3):425-42.
[Ageing Res Rev. 2002]Dev Cell. 2002 Jan; 2(1):9-19.
[Dev Cell. 2002]Proc Natl Acad Sci U S A. 1998 Oct 27; 95(22):13091-6.
[Proc Natl Acad Sci U S A. 1998]Science. 2003 Feb 28; 299(5611):1342-6.
[Science. 2003]Science. 2003 May 16; 300(5622):1140-2.
[Science. 2003]Bioessays. 2001 Dec; 23(12):1112-9.
[Bioessays. 2001]J Biol Chem. 2003 Jul 18; 278(29):27016-23.
[J Biol Chem. 2003]Bioessays. 2001 Dec; 23(12):1112-9.
[Bioessays. 2001]Curr Biol. 2000 Oct 19; 10(20):1247-55.
[Curr Biol. 2000]Mol Cell. 2001 May; 7(5):1085-94.
[Mol Cell. 2001]J Biol Chem. 2004 Mar 26; 279(13):12005-8.
[J Biol Chem. 2004]Nature. 2004 Apr 1; 428(6982):569-74.
[Nature. 2004]Nature. 2002 Oct 24; 419(6909):808-14.
[Nature. 2002]Bioessays. 2001 Dec; 23(12):1112-9.
[Bioessays. 2001]Genetics. 2002 Jul; 161(3):1101-12.
[Genetics. 2002]Nature. 2002 Oct 24; 419(6909):808-14.
[Nature. 2002]Eur J Biochem. 1989 Dec 8; 186(1-2):123-8.
[Eur J Biochem. 1989]Biochem J. 2000 Feb 1; 345 Pt 3():437-43.
[Biochem J. 2000]Bioessays. 2001 Dec; 23(12):1112-9.
[Bioessays. 2001]Biogerontology. 2000; 1(1):15-29.
[Biogerontology. 2000]J Gerontol A Biol Sci Med Sci. 2002 Mar; 57(3):B109-14.
[J Gerontol A Biol Sci Med Sci. 2002]J Gerontol. 1994 Nov; 49(6):B270-6.
[J Gerontol. 1994]J Anat. 2000 Nov; 197 Pt 4():587-90.
[J Anat. 2000]Dev Cell. 2002 Jan; 2(1):9-19.
[Dev Cell. 2002]Nature. 1993 Dec 2; 366(6454):461-4.
[Nature. 1993]Nature. 1993 Dec 2; 366(6454):461-4.
[Nature. 1993]Dev Cell. 2002 Jan; 2(1):9-19.
[Dev Cell. 2002]Science. 1997 Nov 14; 278(5341):1319-22.
[Science. 1997]J Biol. 2003; 2(4):28.
[J Biol. 2003]Curr Biol. 2003 Nov 11; 13(22):2004-8.
[Curr Biol. 2003]Proc Natl Acad Sci U S A. 2004 Mar 9; 101(10):3329-35.
[Proc Natl Acad Sci U S A. 2004]Development. 2000 Apr; 127(7):1467-75.
[Development. 2000]Nature. 1999 Dec 16; 402(6763):804-9.
[Nature. 1999]Nature. 1999 May 27; 399(6734):362-6.
[Nature. 1999]FEBS Lett. 2001 Sep 21; 505(3):348-52.
[FEBS Lett. 2001]EMBO J. 2002 Dec 2; 21(23):6367-76.
[EMBO J. 2002]Science. 2003 Feb 28; 299(5611):1346-51.
[Science. 2003]Science. 1997 Nov 14; 278(5341):1319-22.
[Science. 1997]Biotechniques. 2002 Apr; 32(4):728-30.
[Biotechniques. 2002]Methods Mol Biol. 2000; 99():63-74.
[Methods Mol Biol. 2000]Nature. 1999 Dec 16; 402(6763):804-9.
[Nature. 1999]Nature. 2002 Oct 24; 419(6909):808-14.
[Nature. 2002]Anal Biochem. 1985 Apr; 146(1):118-24.
[Anal Biochem. 1985]J Gerontol. 1994 Nov; 49(6):B270-6.
[J Gerontol. 1994]Nature. 1999 Dec 16; 402(6763):804-9.
[Nature. 1999]Dev Cell. 2001 Nov; 1(5):633-44.
[Dev Cell. 2001]